Re: Just pathetic
|
1
|
Resverlogix Corp.
|
Sep 18, 2024 07:31PM
|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
1
|
Resverlogix Corp.
|
Jun 14, 2023 03:47PM
|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
|
Resverlogix Corp.
|
Jun 14, 2023 03:46PM
|
Re: "Do we actually have a Breakthrough Therapy Designation?"
|
1
|
Resverlogix Corp.
|
Jun 14, 2023 03:44PM
|
Re: "Do we actually have a Breakthrough Therapy Designation?"
|
1
|
Resverlogix Corp.
|
Jun 14, 2023 10:38AM
|
Re: Ownership Update
|
|
Resverlogix Corp.
|
Feb 27, 2023 12:19PM
|
BeardownAZ
|
3
|
Resverlogix Corp.
|
Jan 18, 2023 08:51AM
|
Re: IR
|
4
|
Resverlogix Corp.
|
Jan 18, 2023 08:45AM
|
Re: Another quarter and not a peep
|
1
|
Resverlogix Corp.
|
Jan 13, 2023 01:22PM
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
|
Resverlogix Corp.
|
Nov 30, 2022 12:26PM
|
Vas. Dementia pipeline RVX?
|
3
|
Resverlogix Corp.
|
Nov 30, 2022 12:19PM
|
Interesting 50 day move
|
1
|
Resverlogix Corp.
|
Nov 20, 2022 11:11AM
|
Interesting 50 day move
|
1
|
Resverlogix Corp.
|
Nov 20, 2022 11:11AM
|
Re: find it interesting that RVXCF.....
|
1
|
Resverlogix Corp.
|
Nov 17, 2022 12:18AM
|
INTERESTING BIG PHARMA ON HUNT?
|
5
|
Resverlogix Corp.
|
Nov 09, 2022 08:15PM
|
interesting in re INFLAMATION
|
3
|
Resverlogix Corp.
|
Oct 10, 2022 11:49AM
|
Re: Looking forward now , can/will management use this meeting as the start of many positive updates?
|
2
|
Resverlogix Corp.
|
Aug 29, 2022 05:41PM
|
Re: Interesting New Lipid Standards
|
1
|
Resverlogix Corp.
|
Jul 24, 2022 08:23PM
|
Interesting New Lipid Standards
|
2
|
Resverlogix Corp.
|
Jul 24, 2022 08:22PM
|
Re: Thrown in the towel?
|
2
|
Resverlogix Corp.
|
Jul 23, 2022 08:54PM
|